Do stem cell-derived islets represent a commercially viable treatment for Type 1 and 2 diabetes?

Regen Med. 2010 Nov;5(6):839-42. doi: 10.2217/rme.10.75.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 1 / economics*
  • Diabetes Mellitus, Type 1 / therapy*
  • Diabetes Mellitus, Type 2 / economics*
  • Diabetes Mellitus, Type 2 / therapy*
  • Humans
  • Islets of Langerhans / cytology*
  • Islets of Langerhans Transplantation / economics*
  • Marketing
  • Models, Biological
  • Stem Cell Transplantation / economics*
  • Stem Cells / cytology*
  • Sus scrofa
  • Transplantation, Heterologous